John H. Markels, Ph.D.
Board Member
Sangamo Therapeutics, Inc (SGMOQ)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John H. Markels, Ph.D.
John H. Markels, Ph.D. is recorded as Board Member at Sangamo Therapeutics, Inc (SGMOQ). Sangamo Therapeutics, Inc reported in an 8-K filed June 16, 2025 that John H. Markels, Ph.D. was appointed Director, effective June 12, 2025. Sangamo Therapeutics, Inc reported in an 8-K filed June 5, 2024 that John H. Markels, Ph.D. was appointed Director, effective June 4, 2024. Sangamo Therapeutics, Inc reported in an 8-K filed June 2, 2023 that John H. Markels, Ph.D. was appointed Director, effective June 1, 2023.
“Each of the nominees for director listed in the Proxy Statement was elected by the votes set forth below:”
“Each of the nominees for director listed in the Proxy Statement was elected by the votes set forth below:”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-06-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sangamo Therapeutics, Inc
Other people whose current roles at this company are on record from its filings.
- Alexander D. Macrae CEO, Board Member
- Kathy Y. Yi CFO
- Nikunj Jain CFO, Chief Accounting Officer
- Sung H. Lee CFO
- D. Mark McClung COO
- Scott B. Willoughby General Counsel
- Alexander D. Macrae, M.B., Ch.B., Ph.D. Board Member
- Courtney Beers Board Member
- Courtney Beers, Ph.D. Board Member
- Courtney Beers, PhD. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.